- Home
- BBNX vs EDD Comparison
BBNX vs EDD Comparison
Compare BBNX & EDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBNX | EDD |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | United States |
| Employees | 423 | N/A |
| Industry | Medical/Dental Instruments | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.1M | 397.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BBNX | EDD |
|---|---|---|
| Price | $10.94 | $5.56 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $26.22 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 481.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.52% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $34.99 | N/A |
| Revenue Next Year | $34.47 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.89 | $4.28 |
| 52 Week High | $32.71 | $6.18 |
Technical Indicators
Market Signals| Indicator | BBNX | EDD |
|---|---|---|
| Relative Strength Index (RSI) | 25.81 | 30.95 |
| Support Level | N/A | $5.45 |
| Resistance Level | $15.53 | $5.69 |
| Average True Range (ATR) | 0.70 | 0.10 |
| MACD | 0.11 | -0.07 |
| Stochastic Oscillator | 20.75 | 23.24 |
Price Performance
Historical ComparisonAbout BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.
Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.